Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption
Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing